Table 2.
Predictor | Bivariate IRR (95% CI) |
P Value |
Multivariable IRR (95% CI) |
P Value |
---|---|---|---|---|
Patient age | 0.99 (0.96 – 1.02) | 0.54 | 0.99 (0.96 – 1.02) | 0.43 |
Male sex | 1.11 (0.41 – 3.00) | 0.84 | † | |
Non-white race | 0.75 (0.19 – 3.03) | 0.69 | † | |
Number of medications at baseline | 1.03 (0.99 – 1.06) | 0.09 | 1.03 (0.99 – 1.08) | 0.16 |
High-risk medications used at baseline | ||||
Glucose-lowering drug | 0.65 (0.44 – 0.95) | 0.03 | 0.61 (0.41 – 0.91) | 0.02 |
Loop diuretic | 1.25 (0.91 – 1.73) | 0.17 | 1.20 (0.81 – 1.78) | 0.37 |
Digoxin | 1.10 (0.66 – 1.85) | 0.71 | 1.06 (0.59 – 1.89) | 0.86 |
Anticonvulsant | 0.88 (0.50 – 1.55) | 0.66 | 0.79 (0.44 – 1.43) | 0.44 |
Any Beers criteria drug | 0.96 (0.54 – 1.74) | 0.91 | 0.95 (0.51 – 1.76) | 0.86 |
Warfarin | 0.87 (0.41 – 1.86) | 0.72 | † | |
Benzodiazepine | 0.70 (0.31 – 1.59) | 0.40 | † | |
Number of high-risk medications at baseline ‡ | 0.94 (0.79 – 1.11) | 0.45 | 0.84 (0.69 – 1.03) * | 0.10 |
Self-reported health score ≥ 75 | 1.12 (0.81 – 1.54) | 0.49 | 1.21 (0.86 – 1.70) | 0.28 |
IADL dependencies (Ref: Fully independent) | ||||
Mild dependence | 1.18 (0.81 – 1.72) | 0.80 | 1.25 (0.84 – 1.86) | 0.95 |
Moderate or severe dependence | 0.98 (0.61 – 1.56) | 0.91 (0.54 – 1.54) | ||
Geriatric conditions | ||||
Cognitive impairment | 1.11 (0.73 – 1.68) | 0.63 | 1.12 (0.72 – 1.72) | 0.62 |
Depression | 1.10 (0.73 – 1.68) | 0.65 | 0.95 (0.60 – 1.49) | 0.82 |
Visual impairment | 0.69 (0.41 – 1.18) | 0.18 | 0.69 (0.39 – 1.21) | 0.19 |
Incontinence | 1.18 (0.70 – 2.01) | 0.53 | 1.01 (0.57 – 1.77) | 0.98 |
Constipation | 0.88 (0.45 – 1.72) | 0.70 | 0.77 (0.38 – 1.55) | 0.47 |
Fall or gait instability | 1.91 (0.78 – 4.65) | 0.15 | 1.91 (0.71 – 5.14) | 0.20 |
Geriatric burden score* (Ref: 0) | ||||
1 | 0.95 (0.68 – 1.33) | 0.81 | 0.84 (0.58 – 1.21) * | 0.79 |
2 or more | 1.13 (0.70 – 1.81) | 1.04 (0.63 – 1.73) * | ||
Other comorbid conditions | ||||
Congestive heart failure | 1.26 (0.77 – 2.09) | 0.36 | 0.97 (0.50 – 1.87) | 0.93 |
Chronic renal insufficiency | 0.83 (0.46 – 1.50) | 0.55 | 0.76 (0.41 – 1.40) | 0.37 |
Number of comorbidities (Ref: < 10) | ||||
10 – 13 comorbidities | 1.14 (0.79 – 1.66) | 0.37 | 1.17 (0.78 – 1.76) | 0.57 |
≥ 14 comorbidities | 1.18 (0.82 – 1.71) | 1.14 (0.71 – 1.84) | ||
Study group (intervention vs. control) | 0.94 (0.70 – 1.28) | 0.70 | 0.89 (0.64 – 1.23) | 0.47 |
Geriatric burden score is collinear with IADL dependencies and the geriatric conditions listed in the table, and the number of high-risk medications is collinear with the specific high-risk medications listed in the table. The multivariable parameter estimates for these summative variables are derived from separate models that excluded the collinear covariates. Results are combined into a single table for clarity of presentation.
Male sex, non-white race, and use of warfarin and benzodiazepines were not included in the multivariable model to preserve statistical power for the remaining covariates (see methods).
Not counting Beers criteria drugs (to prevent double-counting, since certain benzodiazepines and higher-dose digoxin prescriptions are counted as Beers criteria drugs).